Utilizing Tiny-TIM to Assess the Effect of Acid-Reducing Agents on the Absorption of Orally Administered Drugs
Authors:
- 1 August 2021
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 110 (8) , 3020-3026
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Impact of Acid-Reducing Agents on Gastrointestinal Physiology and Design of Biorelevant Dissolution Tests to Reflect These ChangesJournal of Pharmaceutical Sciences, 2019
- The cytochrome P450 isoenzyme and some new opportunities for the prediction of negative drug interaction in vivoDrug Design, Development and Therapy, 2018
- Prediction of Hepatic Efflux Transporter-Mediated Drug Interactions: When Is it Optimal to Measure Intracellular Unbound Fraction of Inhibitors?Journal of Pharmaceutical Sciences, 2017
- Proton Pump Inhibitor Usage and the Risk of Myocardial Infarction in the General PopulationPLOS ONE, 2015
- Managing potential drug-drug interactions between gastric acid-reducing agents and antiretroviral therapy: experience from a large HIV-positive cohortInternational Journal of STD & AIDS, 2015
- Pharmacokinetic Drug Interaction Profiles of Proton Pump Inhibitors: An UpdateDrug Safety, 2014
- Drug–Drug Interaction Studies: Regulatory Guidance and An Industry PerspectiveThe AAPS Journal, 2013
- Systematic review: impaired drug absorption related to the co‐administration of antisecretory therapyAlimentary Pharmacology & Therapeutics, 2009
- Lack of Effect of Gastric Acid-Reducing Agents on the Pharmacokinetics of Lopinavir/Ritonavir in HIV-Infected PatientsAIDS Patient Care and STDs, 2007
- Drug Interaction Studies: Study Design, Data Analysis, and Implications for Dosing and LabelingClinical Pharmacology & Therapeutics, 2007